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background:  Risk of future coronary heart disease (CHD) among individuals with diabetes and ‘metabolic dyslipidemia’ (high triglycerides 
[TG] and low HDL-C levels) remains a matter of concern. Little is known regarding risk of CHD for this phenotype with LDL-C levels <100 
mg/dl.
Methods:  We analyzed a diabetes cohort of 28,318 members of Kaiser Permanente Northern California (follow up time 2002-2011), 
with low LDL-C levels (<100 mg/dl) and without known CHD. We compared the incidence and hazard ratios (HRs) for CHD events in four 
groups using Cox models: normal HDL and normal TG (reference); normal HDL and high TG (≥150 mg/dl); low HDL (≤50 mg/dl for women 
and ≤40 mg/dl for men) and normal TG; low HDL and high TG (metabolic dyslipidemia).
Results:  Within this cohort (ages 30 - 90years), 12,508 (44%) had metabolic dyslipidemia. Age-adjusted CHD events/1000 person 
years (p-y) were highest among this subgroup (12.7/1000 p-y and 19 /1000 p-y for women and men, respectively). After multivariable 
adjustment (Table), we observed an increased CHD risk in women (HR 1.30, 95% CI: 1.1-1.5) and men (HR 1.48, 95% CI: 1.3-1.67) 
with metabolic dyslipidemia. The increased risk remained significant after additional adjustment for statin use.
conclusion:  Metabolic dyslipidemia in adults with diabetes is associated with an increased risk of CHD, even in individuals with a LDL-C < 
100. Effective CHD prevention strategies to address this high risk diabetes subset are needed.
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